18 Oct 2024 07:00
RNS Number : 6785I
Cambridge Cognition Holdings PLC
18 October 2024
18 October 2024
Cambridge Cognition Holdings plc
("Cambridge Cognition", the "Company" or the "Group")
Directorate change
Cambridge Cognition Holdings Plc (AIM: COG), which develops and markets digital solutions to assess brain health, announces that, further to the announcement made on 12 September 2024 in which it stated that Dr Matthew Stork had stepped down as Chief Executive Officer, the Company has now received the formal resignation of Dr Stork as a Director of the Company and all subsidiary entities of which he was a Director.
Enquiries:
Cambridge Cognition Holdings plc Dr Steven Powell, Chairman | c/o Hudson Sandler | Panmure Liberum Limited (NOMAD and Joint Broker) Freddy Crossley / Will Goode / Mark Rogers Rupert Dearden | Tel: 020 7886 2968 (Corporate Finance) (Corporate Broking) | Dowgate Capital Limited (Joint Broker) David Poutney / James Serjeant | Tel: 020 3903 7715 | Hudson Sandler (Financial PR and IR) Dan de Belder / Hattie Dreyfus / Harry Griffiths | Tel: 020 7796 4133 cog@hudsonsandler.com |
|
|
Notes to Editors
About Cambridge Cognition
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
For further information visit: https://cambridgecognition.com/
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOAGZMMGRNMGDZM
Sign In
Last checked at 
Follow the stocks
